|
KIAA1522 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.56303875292951E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.2395201772556E-12 |
| Normal-vs-Stage2 |
6.041900E-03 |
| Normal-vs-Stage3 |
3.49519999609527E-08 |
| Normal-vs-Stage4 |
3.317100000233E-07 |
| Stage1-vs-Stage2 |
1.353000E-01 |
| Stage1-vs-Stage3 |
7.716600E-01 |
| Stage1-vs-Stage4 |
6.481600E-01 |
| Stage2-vs-Stage3 |
2.398200E-01 |
| Stage2-vs-Stage4 |
1.218950E-01 |
| Stage3-vs-Stage4 |
5.253400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.45157236125715E-12 |
| Normal-vs-AfricanAmerican |
3.812300E-04 |
| Normal-vs-Asian |
6.56080000327464E-08 |
| Caucasian-vs-AfricanAmerican |
6.797000E-01 |
| Caucasian-vs-Asian |
2.339000E-01 |
| AfricanAmerican-vs-Asian |
6.792000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.26179955373118E-10 |
| Normal-vs-Female |
3.49930084908578E-11 |
| Male-vs-Female |
2.378200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.4500957646344E-11 |
| Normal-vs-Age(41-60Yrs) |
1.18720033803754E-10 |
| Normal-vs-Age(61-80Yrs) |
1.85406999999582E-05 |
| Normal-vs-Age(81-100Yrs) |
1.020410E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.487200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.034970E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.896200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.573240E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.369400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.485000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.094400E-01 |
| Classical-VS-Follicular |
4.00229849262246E-11 |
| Classical-VS-Other |
5.732400E-01 |
| Classical-VS-Normal |
1.62458935193399E-12 |
| Tall-VS-Follicular |
1.244970E-04 |
| Tall-VS-Other |
7.832000E-01 |
| Tall-VS-Normal |
8.91000000446951E-08 |
| Follicular-VS-Other |
1.263570E-01 |
| Follicular-VS-Normal |
3.301000E-01 |
| Other-VS-Normal |
3.259700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.83760000128342E-08 |
| Normal-vs-N1 |
7.7647999996433E-07 |
| N0-vs-N1 |
2.564600E-01 |
|
|
